Penumbra (PEN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Top Gap Ups and Downs on Wednesday: MLI, MSTR, GSK and More
Moomoo NewsDec 11 18:00 ET · Markets
Price Over Earnings Overview: Penumbra
BenzingaDec 11 12:00 ET
Penumbra Shares Are Trading Higher After Wells Fargo Upgraded the Stock From Equal-Weight to Overweight and Raised Its Price Target From $190 to $275.
BenzingaDec 11 11:02 ET
12 Analysts Assess Penumbra: What You Need To Know
BenzingaDec 11 11:01 ET
Citi Maintains Penumbra(PEN.US) With Hold Rating, Raises Target Price to $245
Moomoo NewsDec 11 07:33 ET · Ratings
Wells Fargo Upgrades Penumbra to Overweight From Equalweight, Price Target Is $190
MT NewswiresDec 11 07:31 ET · Ratings

Comments

Moomoo AI

Feb 22 11:42

Despite the high P/S ratio, shareholders are holding onto Penumbra's stocks due to its strong future revenue prospects. The strong revenue forecasts are expected to keep the share price buoyant unless the analysts have significantly misjudged the company's potential.

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Chatterbox Moo

Nov 21, 2023 04:20

Columns Medical-device Stock Selloff Caused by Ozempic Fears Has Gone Too Far—Now They're Rebounding

A new generation of highly effective weight-loss and diabetes drugs known as GLP-1s has led Wall Street to spell doom for companies that have profited from obesity problem. However, the reaction on Wall Street has been extreme, creating opportunities for cooler heads, some analysts and investors say.
To be sure, drugs such as $Novo-Nordisk A/S (NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...

11

Moomoo AI

Nov 9, 2023 05:00

Penumbra's earnings outlook could be brighter than reflected in the statutory profit due to one-off items. The company's profitability this year shows a good sign after previous losses.

The Strong Earnings Posted By Penumbra (NYSE:PEN) Are A Good Indication Of The Strength Of The Business

Moomoo AI

Nov 3, 2023 12:00

Penumbra's low ROE and declining net income over five years hint at sub-par performance. The earnings' decline, despite profit retention, could imply a struggling business or high payout ratio. Analyst estimates, however, foresee a better earnings growth rate.

Is Penumbra, Inc.'s (NYSE:PEN) Recent Price Movement Underpinned By Its Weak Fundamentals?

Mooers Radar

Aug 2, 2023 19:28

Columns US Top Gap Ups and Downs on 8/2: VRT, AZPN, DRVN, TEF and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Vertiv Holdings (VRT.US)$ - up 18.6%
2. $Erie Indemnity (ERIE.US)$ - up 8.7%
3. $Aspen Technology (AZPN.US)$ - up 6.5%
4. $Penske Automotive (PAG.US)$ - up 5.1%
5. $Humana (HUM.US)$ - up 3.7%
6. $Teva Pharmaceutical Industries (TEVA.US)$ - up 3.7%
7. $Encompass Health (EHC.US)$ - up 3.0%
8. $Emerson Electric (EMR.US)$ - up 2.8...

+16

11

3

PEN Penumbra

Trade Overview

Capital Trend

News

Comments